Common side effects reported with retatrutide include: Nausea, vomiting, and diarrhoea (most frequent, particularly during dose escalation) Decreased appetite Constipation Injection site reactions Mild increases in heart rate Cagrilintide has demonstrated a generally well-tolerated profile, with gastrointestinal symptoms also being the most commonly reported adverse effects
Aids in the regeneration of other antioxidants like vitamins C and E
Timing Baseline Marker Comprehensive metabolic panel (CMP) Why it matters Reviews liver, kidney, electrolyte, and glucose context before interpreting energy changes
A laboratory grade compound is not synthesized, filled, or sealed under the sterile conditions required for an injectable drug, and contamination can range from endotoxin to bacterial growth that the patient cannot see or smell
It is not known if Zepbound can be used in people who have had pancreatitis